Organogenesis Holdings (ORGO) Total Debt (2017 - 2024)

Organogenesis Holdings' Total Debt history runs 8 years deep, the most recent figure standing at $62.1 million for Q3 2024.

• In Q3 2024, Total Debt fell 8.11% year-over-year to $62.1 million; the TTM figure through Sep 2024 stood at $62.1 million (down 8.11% YoY), while the FY2023 annual figure was $66.2 million, down 6.41% from the prior year.
• Total Debt was $62.1 million for Q3 2024 at Organogenesis Holdings, down from $63.5 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $73.4 million in Q4 2021 to a low of $2.2 million in Q3 2021.
• Historically, Total Debt has averaged $56.0 million across 5 years, with a median of $64.9 million in 2024.
• The sharpest annual moves came in 2021 and 2022: Total Debt slumped 96.34% in 2021, then jumped 3221.32% in 2022.
• A 5-year view of Total Debt shows it stood at $26.7 million in 2020, then jumped by 175.35% to $73.4 million in 2021, then decreased by 3.62% to $70.8 million in 2022, then fell by 6.41% to $66.2 million in 2023, then slipped by 6.21% to $62.1 million in 2024.
• The last three Total Debt figures came in at $62.1 million (Q3 2024), $63.5 million (Q2 2024), and $64.9 million (Q1 2024), per Business Quant data.